Chardan Capital Has Positive Outlook of OBIO FY2025 Earnings
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Free Report) – Equities researchers at Chardan Capital upped their FY2025 earnings per share (EPS) estimates for Orchestra BioMed in a research note issued to investors on Wednesday, April 2nd. Chardan Capital analyst K. Nakae now anticipates that the company will post earnings of ($1.88) per share for the […]
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Free Report) – Equities researchers at Chardan Capital upped their FY2025 earnings per share (EPS) estimates for Orchestra BioMed in a research note issued to investors on Wednesday, April 2nd. Chardan Capital analyst K. Nakae now anticipates that the company will post earnings of ($1.88) per share for the […]
